Drug Trial Radar · NCT07617597
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata
Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
78
Planned (sponsor's estimate)
Start
Jun 19, 2026
Primary completion
Feb 2028
Study completion Sep 2028
Sponsor
- Lead sponsor
- Sun Pharma Japan LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jun 1, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the efficacy and safety of deuruxolitinib in Japanese Adults between 18 and 65 years of age who have 50% or greater scalp hair loss.
Conditions
- Alopecia Areata
Interventions
DeuruxolitinibDrug
Deuruxolitinib will be dosed orally as tablets at a dose of 8 mg
PlaceboDrug
Deuruxolitinib matching placebo will be dosed orally as tablets for up to 24 weeks and then deuruxolitinib will be dosed for up to 52 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of subjects achieving an absolute SALT score of 20 or lessTime frame: Week 24
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Study Site 102
Asahikawa, Japan · Recruiting
Study Site 117
Bunkyō City, Japan · Recruiting
Study Site 119
Ebina, Japan · Recruiting
Study Site 101
Hamamatsu, Japan · Recruiting
Study Site 116
Ishikawa, Japan · Recruiting
Study Site 112
Kitakyushu, Japan · Recruiting
Study Site 118
Kōtoku, Japan · Recruiting
Study Site 110
Kurashiki, Japan · Recruiting
Study Site 113
Kurume, Japan · Recruiting
Study Site 107
Kyoto, Japan · Recruiting
Study Site 106
Mitaka-shi, Japan · Recruiting
Study Site 114
Miyagi-gun, Japan · Withdrawn
Study Site 104
Niigata, Japan · Recruiting
Study Site 109
Osaka, Japan · Recruiting
Study Site 108
Osaka, Japan · Recruiting
Study Site 103
Sapporo, Japan · Recruiting
Study Site 105
Shinjuku-Ku, Japan · Recruiting
Study Site 111
Ube, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.